Hoffman Robert E. 4
4 · Kintara Therapeutics, Inc. · Filed Feb 17, 2022
Insider Transaction Report
Form 4
Hoffman Robert E.
Director
Transactions
- Purchase
Common Stock
2022-02-15$0.47/sh+55,000$25,795→ 55,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4625 to $0.4697 per share, inclusive. The reporting person undertakes to provide to Kintara Therapeutics, Inc., any security holder of Kintara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.